Barclays Has Lowered Expectations for Molina Healthcare (NYSE:MOH) Stock Price

Molina Healthcare (NYSE:MOH - Free Report) had its price objective decreased by Barclays from $362.00 to $351.00 in a research note released on Monday,Benzinga reports. Barclays currently has an equal weight rating on the stock.

MOH has been the topic of several other reports. UBS Group dropped their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Truist Financial boosted their target price on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Robert W. Baird reiterated a "neutral" rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Wall Street Zen upgraded Molina Healthcare from a "hold" rating to a "buy" rating in a research note on Friday, April 11th. Finally, Guggenheim began coverage on Molina Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Nine analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, Molina Healthcare currently has an average rating of "Hold" and an average target price of $364.54.

Molina Healthcare Trading Down 1.3%

MOH traded down $3.93 during trading hours on Monday, reaching $293.42. 654,528 shares of the company's stock traded hands, compared to its average volume of 684,723. The firm has a 50-day moving average price of $322.49 and a 200 day moving average price of $307.19. Molina Healthcare has a 52-week low of $262.32 and a 52-week high of $365.23. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $15.90 billion, a PE ratio of 14.36, a PEG ratio of 1.06 and a beta of 0.63.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Molina Healthcare's revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the company posted $5.73 EPS. As a group, sell-side analysts predict that Molina Healthcare will post 24.4 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director now directly owns 11,244 shares of the company's stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares in the company, valued at $82,484,262.90. This represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC grew its stake in Molina Healthcare by 123.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock worth $100,000 after purchasing an additional 192 shares in the last quarter. SYM FINANCIAL Corp acquired a new position in shares of Molina Healthcare during the 4th quarter worth about $249,000. Summit Trail Advisors LLC acquired a new position in shares of Molina Healthcare during the 4th quarter worth about $452,000. Entropy Technologies LP boosted its position in shares of Molina Healthcare by 58.1% during the 4th quarter. Entropy Technologies LP now owns 4,594 shares of the company's stock worth $1,337,000 after acquiring an additional 1,688 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of Molina Healthcare during the 4th quarter worth about $10,725,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.